Host-directed therapies against tuberculosis

This publication has 9 references indexed in Scilit:

• Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial
  The Lancet Respiratory Medicine, 2014
• Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment
  Proceedings of the National Academy of Sciences, 2012
• When to Start Antiretroviral Therapy in HIV-Associated Tuberculosis
  New England Journal of Medicine, 2011
• Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review
  International Journal of Infectious Diseases, 2011
• Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome
  AIDS, 2010
• Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults
  New England Journal of Medicine, 2004
• Adjunctive Thalidomide Therapy for Childhood Tuberculous Meningitis: Results of a Randomized Study
  Journal of Child Neurology, 2004
• Randomized Trial of Adjunctive Interleukin-2 in Adults with Pulmonary Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2003
• CONTROLLED CLINICAL TRIAL OF COMPLETE OPEN SURGICAL DRAINAGE AND OF PREDNISOLONE IN TREATMENT OF TUBERCULOUS PERICARDIAL EFFUSION IN TRANSKEI
  The Lancet, 1988